Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
68.50    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £60.33m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Offer Update

30 May 2007 17:41

Stornoway Limited30 May 2007 Stornoway has received irrevocable undertakings to vote in favour of theAcquisition, the Scheme and the resolutions to be proposed at the EGM (includingthe Rule 16 Resolution) in respect of the entire beneficial holdings of LordGrabiner, amounting in aggregate to 350,515 Calyx Shares, and Lord Wolfson,amounting in aggregate to 350,515 Calyx Shares, representing, in aggregate, 1.00per cent. of the existing issued share capital of Calyx. Both irrevocable undertakings will cease to be binding if Stornoway announcesthat it will not proceed to make the Acquisition, or the Scheme Document has notbeen posted by the twenty-eighth day after the announcement of a firm intentionto make the Acquisition made by Stornoway on 25 May 2007 (or such later date asStornoway and Calyx may agree, with the consent of the Panel), or the Schemedoes not become effective by 30 September 2007 (or such later date as Stornowayand Calyx may, with the consent of the Panel, agree and the High Court mayallow), or the Scheme fails to become effective or is withdrawn, or if a highercompeting offer for Calyx is announced which is at least 10 per cent. higherthan 101 pence per Calyx Share. As a consequence of receiving this irrevocable undertaking: • Stornoway has received irrevocable undertakings to vote, or procure a vote, in favour of the Scheme in respect of a total of 23,086,596 Calyx Shares representing, in aggregate, 100.00 per cent. of the existing issued share capital of Calyx entitled to vote at the Court Meeting for Stornoway Class Shareholders. • Stornoway has received irrevocable undertakings or letters of intent to vote, or procure a vote, in favour of the Scheme in respect of a total of 18,118,093 Calyx Shares representing, in aggregate, 39.01 per cent. of the existing issued share capital of Calyx entitled to vote at the Court Meeting for Calyx Shareholders other than Stornoway Class Shareholders. • Stornoway has received irrevocable undertakings or letters of intent to vote, or procure a vote, in favour of the resolutions to be proposed at the EGM (other than the Rule 16 Resolution) in respect of a total of 41,204,689 Calyx Shares representing, in aggregate, 59.26 per cent. of the existing issued share capital of Calyx entitled to vote on those resolutions. • Stornoway has received irrevocable undertakings or letters of intent to vote, or procure a vote, in favour of the Rule 16 Resolution at the EGM in respect of a total of 21,032,951 Calyx Shares representing, in aggregate, 42.62 per cent. of the existing issued share capital of Calyx held by the Independent Shareholders, who are the only Calyx Shareholders entitled to vote on the Rule 16 Resolution. For the purpose of this announcement, the existing issued share capital of Calyxis based upon the 69,526,914 Calyx Shares in issue as at 30 May 2007. Unless otherwise defined terms used in this announcement have the same meaningas in the announcement of a firm intention to make the Acquisition made byStornoway on 25 May 2007. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20267:30 amRNSDirector Dealing
29th May 20263:00 pmRNSExercise of Options and Total Voting Rights
26th May 20267:00 amRNSFinal Results
14th May 20267:00 amRNSNotice of Presentations
13th Apr 20267:00 amRNSFY26 Trading Update and Notice of Results
30th Mar 20267:00 amRNSHolding(s) in Company
26th Nov 20257:30 amRNSDirector Dealing
18th Nov 20257:00 amRNSInterim Results
6th Nov 202511:30 amRNS-RCalnex and Viavi Partnership
30th Oct 20257:00 amRNSNotice of Results and Presentations
8th Oct 20252:08 pmRNSExercise of Options and Total Voting Rights
16th Sep 20259:09 amRNSExercise of Options and Total Voting Rights
14th Aug 20254:12 pmRNSResult of AGM
14th Aug 20257:00 amRNSAGM Statement
15th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
16th Jun 20259:52 amRNSLong-Term Incentive Plan Awards
10th Jun 202511:59 amRNSDirector Dealing
20th May 20257:00 amRNSFinal Results
15th May 20257:00 amRNSNotice of Investor Presentation
8th Apr 20257:00 amRNSFY25 Trading Update and Notice of Results
14th Mar 20257:00 amRNSDirector Dealing
29th Jan 202510:48 amRNSExercise of Options
19th Nov 20247:00 amRNSInterim Results
4th Nov 20247:00 amRNSNotice of Results and Investor Presentation
8th Oct 20247:00 amRNSDirector/PDMR Dealing
2nd Oct 20244:57 pmRNSResult of General Meeting
6th Sep 20247:00 amRNSNotice of General Meeting
22nd Aug 20245:18 pmRNSResult of AGM
22nd Aug 20247:00 amRNSAGM Statement
18th Jul 20249:08 amRNSNotice of AGM
17th Jul 20242:00 pmRNSLong-Term Incentive Plan Awards
21st May 20247:00 amRNSFY24 Final Results
10th Apr 20247:00 amRNSNotice of Investor Presentation
3rd Apr 20247:00 amRNSFY24 Trading Update and Notice of Results
21st Feb 20249:28 amRNSExercise of Options
14th Feb 20241:08 pmRNSExercise of Options
12th Dec 20233:47 pmRNSPDMR Dealings
21st Nov 20237:00 amRNSInterim Results
1st Nov 202312:24 pmRNSChange of Nominated Adviser
26th Oct 20237:00 amRNSNotice of Investor Presentation
10th Oct 20233:17 pmRNSTrading Update and Notice of Results
25th Aug 20234:36 pmRNSPDMR Dealings
16th Aug 20231:22 pmRNSResult of AGM
16th Aug 20237:00 amRNSAGM Statement
11th Aug 20232:00 pmRNSLong-Term Incentive Plan Awards
17th Jul 20237:00 amRNSNotice of AGM
12th Jul 202312:05 pmRNSDirector/PDMR Dealings
12th Jun 20234:34 pmRNSPDMR Dealings
23rd May 20237:00 amRNSFY23 Final Results
11th May 20239:00 amRNSPDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.